Explore comprehensive CDMO services offered by ST Pharm, supporting end-to-end Manufacturing. ST Pharm enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: South Korea
Description: ST Pharm is a South Korean CDMO (Contract Development and Manufacturing Organization) and part of the Dong-A Socio Group, specializing in the development and manufacturing of oligonucleotides, mRNA therapeutics, and small molecule APIs. Founded in 1983 as Samchully Pharm, it is a key player in nucleic acid therapeutics, offering services from preclinical to commercial scale, with notable expertise in mRNA technology and lipid nanoparticles (LNPs).
